Obinutuzumab vs rituximab for transplant-eligible patients with mantle cell lymphoma

Authors: Sarkozy, Clémentine, Callanan, Mary, Thieblemont, Catherine, Obéric, Lucie, Burroni, Barbara, Bouabdallah, Krimo, Damaj, Gandhi, Tessoulin, Benoit, Ribrag, Vincent, Houot, Roch, Morschhauser, Franck, Griolet, Samuel, Joubert, Clémentine, Cacheux, Victoria, Delwail, Vincent, Safar, Violaine, Gressin, Remy, Cheminant, Morgane, Delfau-Larue, Marie-Hélène, Hermine, Olivier, Macintyre, Elizabeth, Le Gouill, Steven

Source: In Blood 18 July 2024 144(3):262-271

HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma

Authors: Bourbon, Estelle ^∗, Sesques, Pierre ^∗, Gossez, Morgane, Tordo, Jérémie, Ferrant, Emmanuelle, Safar, Violaine, Wallet, Florent, Aussedat, Guillaume, Maarek, Alizée, Bouafia, Fadhela, Karlin, Lionel, Ghergus, Dana, Golfier, Camille, Lequeu, Hélène, Lazareth, Anne, Schwiertz, Vérane, Viel, Sébastien, Idlhaj, Maryam, Ghesquières, Hervé, Monneret, Guillaume, Bachy, Emmanuel, Venet, Fabienne

Source: In Blood Advances 14 March 2023 7(5):744-755

Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.

Authors: Sarkozy, Clémentine, Chartier, Loïc, Ribrag, Vincent, Gressin, Remy, Geisler, Christian H., Kluin-Nelemans, Hanneke C., Thieblemont, Catherine, Morschhauser, Franck, Lemonnier, François, Safar, Violaine, Tessoulin, Benoît, Oberic, Lucie, Damaj, Ghandi, Ghesquières, Hervé, Bouabdallah, Krimo, Casasnovas, René Olivier, Houot, Roch, Klapper, Wolfram, Burroni, Barbara, Pott, Christiane

Source: Blood Cancer Journal; 4/24/2025, Vol. 15 Issue 1, p1-7, 7p

Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data

Authors: Sehn, Laurie H. ^*, Hertzberg, Mark, Opat, Stephen, Herrera, Alex F., Assouline, Sarit, Flowers, Christopher R., Kim, Tae Min, McMillan, Andrew, Ozcan, Muhit, Safar, Violaine, Salles, Gilles, Ku, Grace, Hirata, Jamie, Chang, Yi Meng, Musick, Lisa, Matasar, Matthew J.

Source: In Blood Advances 25 January 2022 6(2):533-543

Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified

Authors: Bourbon, Estelle, Maucort-Boulch, Delphine, Fontaine, Juliette, Mauduit, Claire, Sesques, Pierre, Safar, Violaine, Ferrant, Emmanuelle, Golfier, Camille, Ghergus, Dana, Karlin, Lionel, Lazareth, Anne, Bouafia, Fadhela, Pica, Gian Matteo, Orsini-Piocelle, Frédérique, Rocher, Clément, Gros, François-Xavier, Parrens, Marie, Dony, Arthur, Rossi, Cédric, Ghesquières, Hervé, Bachy, Emmanuel, Traverse-Glehen, Alexandra ^*, Sarkozy, Clémentine ^{*, *}

Source: In Blood Advances 24 August 2021 5(16):3227-3239

Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma

Authors: Lemonnier, François ^*, Safar, Violaine ^*, Beldi-Ferchiou, Asma, Cottereau, Anne-Ségolène, Bachy, Emmanuel, Cartron, Guillaume, Fataccioli, Virginie, Pelletier, Laura, Robe, Cyrielle, Letourneau, Audrey, Missiaglia, Edoardo, Fourati, Slim, Moles-Moreau, Marie-Pierre, Delmer, Alain, Bouabdallah, Reda, Voillat, Laurent, Becker, Stéphanie, Bossard, Céline, Parrens, Marie, Casasnovas, Olivier, Cacheux, Victoria, Régny, Caroline, Camus, Vincent, Delfau-Larue, Marie-Hélène, Meignan, Michel, de Leval, Laurence, Gaulard, Philippe, Haioun, Corinne

Source: In Blood Advances 26 January 2021 5(2):539-548

Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group

Authors: Le Gouill, Steven ^*, Beldi-Ferchiou, Asma ^*, Alcantara, Marion ^*, Cacheux, Victoria, Safar, Violaine, Burroni, Barbara, Guidez, Stéphanie, Gastinne, Thomas, Canioni, Danielle, Thieblemont, Catherine, Maisonneuve, Hervé, Bodet-Milin, Caroline, Houot, Roch, Oberic, Lucie, Bouabdallah, Krimo, Bescond, Charles, Damaj, Ghandi, Jaccard, Arnaud, Daguindau, Nicolas, Moreau, Anne, Tilly, Hervé, Ribrag, Vincent, Delfau-Larue, Marie-Hélène, Hermine, Olivier, Macintyre, Elizabeth

Source: In The Lancet Haematology November 2020 7(11):e798-e807

Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?

Authors: Gazeau, Nicolas, Beauvais, David, Tilmont, Rémi, Srour, Micha, Ferrant, Emmanuelle, Safar, Violaine, Fouillet, Ludovic, Flandrin-Gresta, Pascale, Gower, Nicolas, Chauvet, Paul, Duployez, Nicolas, Podvin, Benjamin, Demaret, Julie, Huet, Sarah, Sujobert, Pierre, Ghesquières, Hervé, Damaj, Gandhi, Bachy, Emmanuel, Morschhauser, Franck, Yakoub-Agha, Ibrahim, Heiblig, Maël, Sesques, Pierre

Source: Leukemia; 20250101, Issue: Preprints p1-9, 9p

End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy.

Authors: Sesques, Pierre, Karlin, Lionel, Massy, Emmanuel, Maarek, Alizée, Aussedat, Guillaume, Lazareth, Anne, Golfier, Camille, Bouafia-Sauvy, Fadhela, Lequeu, Helene, Ghergus, Dana, Safar, Violaine, Ferrant, Emmanuelle, Bachy, Emmanuel, Ghesquières, Hervé, Confavreux, Cyrille B., Demangel, Delphine, Perrial, Emeline, Dumontet, Charles

Source: Frontiers in Oncology; 2024, p1-6, 6p

Subject Terms: TIME of death, MULTIPLE myeloma, DISEASE progression, CAUSES of death, KIDNEY failure

L’émergence des traitements par cellules CAR-T dans les lymphomes

Authors: Salles, Gilles, Sesques, Pierre, Ferrant, Emmanuelle, Safar, Violaine, Ghesquieres, Hervé, Bachy, Emmanuel

Source: In Bulletin du Cancer December 2018 105 Supplement 2:S168-S177

Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospital.

Authors: Lan, Caroline Le, Belot, Aurélien, Golfier, Camille, Audin, Bérénice, Sesques, Pierre, Bernier, Adeline, Safar, Violaine, Ferrant, Emmanuelle, Lazareth, Anne, Lequeu, Hélène, Karlin, Lionel, Ghergus, Dana, Maarek, Alizée, Aussedat, Guillaume, Idlhaj, Maryam, Salles, Gilles, Cherblanc, Fanny, Bachy, Emmanuel, Ghesquieres, Hervé

Source: Hematological Oncology; Jul2024, Vol. 42 Issue 4, p1-5, 5p

Subject Terms: TEACHING hospitals, HIV infections

Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study.

Authors: Sarkozy, Clémentine, Thieblemont, Catherine, Oberic, Lucie, Moreau, Anne, Bouabdallah, Krimo, Damaj, Gandhi, Gastinne, Thomas, Tessoulin, Benoit, Ribrag, Vincent, Casasnovas, Olivier, Haioun, Corinne, Houot, Roch, Jardin, Fabrice, Van Den Neste, Eric, Cheminant, Morgane, Morschhauser, Franck, Callanan, Mary, Safar, Violaine, Gressin, Remy, Hermine, Olivier

Source: Journal of Clinical Oncology; 3/1/2024, Vol. 42 Issue 7, p769-773, 6p

Diagnosis, prognosis and treatment of patients with gastrointestinal stromal tumour (GIST) and germline mutation of KIT exon 13

Authors: Bachet, Jean-Baptiste, Landi, Bruno, Laurent-Puig, Pierre, Italiano, Antoine, Le Cesne, Axel, Lévy, Philippe, Safar, Violaine, Duffaud, Florence, Blay, Jean-Yves, Emile, Jean-François

Source: In European Journal of Cancer July 2013 49(11):2531-2541

Performance of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 trial.

Authors: Bodet-Milin, Caroline, Morvant, Cyrille, Carlier, Thomas, Frecon, Gauthier, Tournilhac, Olivier, Safar, Violaine, Kraeber-Bodere, Françoise, Le Gouill, Steven, Macintyre, Elizabeth, Bailly, Clément

Source: Scientific Reports; 11/18/2023, Vol. 13 Issue 1, p1-5, 5p

Subject Terms: RADIOMICS, MANTLE cell lymphoma, POSITRON emission tomography, BONE marrow, MONOCLONAL antibodies, STEM cell transplantation, COMPUTED tomography

Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Final Results of a Phase Ib/II Randomized Study and Single-Arm Extension (Ext) Study

Authors: Sehn, Laurie H., Hertzberg, Mark ^*, Opat, Stephen ^*, Herrera, Alex F., Assouline, Sarit, Flowers, Christopher R., Kim, Tae Min ^*, McMillan, Andrew K., Özcan, Muhit ^*, Safar, Violaine ^*, Salles, Gilles, Hirata, Jamie, Yang, Annie ^*, Musick, Lisa ^*, Matasar, Matthew J.

Source: In Blood 15 November 2022 140 Supplement 1:9464-9467

Outcome in Multiple Myeloma Patients Treated in the Era of Modern Therapies Who Were Admitted to Intensive Care: A Retrospective Analysis from a Teaching Hospital between 2014 and 2019

Authors: Gross, Zofia ^*, Idlhaj, Maryam ^*, Karlin, Lionel ^*, Friggeri, Arnaud ^*, Lazareth, Anne ^*, Golfier, Camille ^*, Lequeu, Helene ^*, Bouafia Sauvy, Fadhela ^*, Sesques, Pierre ^*, Safar, Violaine ^*, Ferrant, Emmanuelle ^*, Ghergus, Dana ^*, Maarek, Alizee ^*, Aussedat, Guillaume ^*, Salles, Gilles, Bachy, Emmanuel ^*, Wallet, Florent ^*, Ghesquieres, Herve ^*

Source: In Blood 15 November 2022 140 Supplement 1:13099-13101

Flare-up phenomenon or pseudoprogression after CAR T-cell infusion in non-Hodgkin aggressive lymphomas.

Authors: Sortais, Clara, Cordeil, Stéphanie, Bourbon, Estelle, Idlhaj, Maryam, Ferrant, Emmanuelle, Safar, Violaine, Golfier, Camille, Lazareth, Anne, Bouafia-Sauvy, Fadhela, Tordo, Jérémie, Ghesquières, Hervé, Sesques, Pierre, Bachy, Emmanuel

Source: Leukemia & Lymphoma; Mar2023, Vol. 64 Issue 3, p707-711, 5p

Subject Terms: DIFFUSE large B-cell lymphomas, T cells, SUPERIOR vena cava syndrome, CIRCULATING tumor DNA, LYMPHOMAS, WALDENSTROM'S macroglobulinemia

Diagnosis-to-Treatment Interval Is an Important Prognostic Factor with a Time-Dependent Effect Predicting Event-Free Survival after 12 Months from First-Line Treatment in Newly Diagnosed Diffuse Large B-Cell Primary CNS Lymphoma

Authors: Laude, Marie-Charlotte ^*, Julia, Edith ^*, Nicolas-Virelizier, Emmanuelle ^*, Antherieu, Gabriel ^*, Safar, Violaine ^*, Rey, Philippe ^*, Ferrant, Emmanuelle ^*, Traverse-Glehen, Alexandra ^*, Chassagne-Clément, Catherine ^*, Meyronet, David ^*, Lazareth, Anne ^*, Lequeu, Helene ^*, Golfier, Camille ^*, Brisou, Gabriel ^*, Ghergus, Dana ^*, Sesques, Pierre ^*, Karlin, Lionel ^*, Salles, Gilles, Bachy, Emmanuel ^*, Ducray, François ^*, Bouafia, Fadhela ^*, Drouet, Youenn ^*, Ghesquieres, Herve ^*

Source: In Blood 5 November 2020 136 Supplement 1:43-45

Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study and Preliminary Results of a Single-Arm Extension

Authors: Sehn, Laurie H., Hertzberg, Mark ^*, Opat, Stephen, Herrera, Alex F., Assouline, Sarit E, Flowers, Christopher, Kim, Tae Min ^*, McMillan, Andrew, Ozcan, Muhit, Safar, Violaine ^*, Salles, Gilles, Musick, Lisa ^*, Hirata, Jamie, Chang, YiMeng ^*, Ku, Grace ^*, Matasar, Matthew J

Source: In Blood 5 November 2020 136 Supplement 1:17-19

Skeletal Muscle Index, As a Measure of Muscle Mass, Is a Significant Prognostic Factor for Newly Diagnosed Diffuse Large B-Cell Primary CNS Lymphoma Patients

Authors: Antherieu, Gabriel, Julia, Edith, Maarek, Alizee, Safar, Violaine, Ferrant, Emmanuelle, Traverse-Glehen, Alexandra, Lazareth, Anne, Lequeu, Helene, Cordeil, Stéphanie, Aussedat, Guillaume, Golfier, Camille, Ghergus, Dana, Sesques, Pierre, Karlin, Lionel, Bouafia Sauvy, Fadhela, Salles, Gilles, Bachy, Emmanuel, Jouanneau, Emmanuel, Ducray, Francois, Boussel, Loic, Ghesquieres, Herve

Source: In Blood 28 November 2023 142 Supplement 1:1764-1764